A RANDOMIZED DOUBLE-BLIND PHASE-III STUDY OF FILGRASTIM (RECOMBINANT HUMAN G-CSF) VS PLACEBO DURING INTENSIVE INDUCTION CHEMOTHERAPY IN 55 TO 69-YEAR OLD PATIENTS (PTS) WITH POOR-PROGNOSIS AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL)

Authors
BASTION Y BOSLY A GISSELBRECHT C REYES F TILLY H HERBRECHT R MICHAUX JL BAUTERS F COIFFIER B
Citation
Y. Bastion et al., A RANDOMIZED DOUBLE-BLIND PHASE-III STUDY OF FILGRASTIM (RECOMBINANT HUMAN G-CSF) VS PLACEBO DURING INTENSIVE INDUCTION CHEMOTHERAPY IN 55 TO 69-YEAR OLD PATIENTS (PTS) WITH POOR-PROGNOSIS AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000143-10000143
Citations number
1
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
82
Issue
10
Year of publication
1993
Supplement
1
Pages
10000143 - 10000143
Database
ISI
SICI code
0006-4971(1993)82:10<10000143:ARDPSO>2.0.ZU;2-1